Market Access
- Tailor-made advice on the market launch of new pharmaceuticals and medical devices
- Analysis and strategic development under conditions according to the Act for restructuring the drug market (AMNOG)
- Study design
- Conception
- Implementation support
- Preparation of benefit dossiers according to §35a SGB V and discussion papers
Contact: Kristin Appel-Grabein
Workplace health promotion
- Consulting and support for
- Problem identification
- Conceptual design of implementation strategies
- Benefit assessments
- Demand analysis
- Economic evaluation of health promoting measures
- Correlation analysis between health promoting organisational structures and economical business success
Contact: Prof. Dr. Natalie Pomorin
Healthcare Consulting
- Consulting and contract research with regards to financing, operational controlling and performance of health care utilisation
- Performance analysis within the hospital sector
- Marketing in hospitals
- Public image of health care facilities
- Analysis of efficiency
- Feasibility studies
- Analytics and diagnostics of productivity in health care
Contact: Prof. Dr. Natalie Pomorin
Health economic evaluation and health services research
- Comprehensive cost of illness analysis
- Cost-effectiveness and cost-benefit studies (along-the-trial as well as modeling approaches) to medical interventions (mainly pharmaceuticals, medical devices) and complex health care concepts
- Implementation and counseling of health services research projects
Contact: PD Dr. Dr. Anja NeumannDr. Janine Biermann-Stallwitz
Health Technology Assessment (HTA) and Systematic Reviews
- Provision of Health Technology Assessment (HTA)
- Systematic reviews
- Preparation of further evidence-syntheses
- Valuation of clinical guidelines
- Appraisal of evidence by various assessment tools and checklists for the quality of reporting
Contact: Kristin Appel-Grabein
Healthcare system, health policy and pharmaceutical regulation
- Analysis of organizational and incentive structures in healthcare systems, including
- questions of risk adjustment
- physician remuneration
- pharmaceutical regulation
- Development of scope for design of health care systems
- Assessment of measures aiming pharmaceutical policy
- Research and advice on issues concerning medical/therapeutic treatment
Contact: Dr. Anke Walendzik
